JANX Q3'26 Earnings: EPS estimate is (0.47) USD
Menos de 1 minuto de lectura
JANX (Janux Therapeutics, Inc.) is set to announce its Q3'26 results on November 10, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).
For Q3'26, revenue estimate is 8.03 million USD with EPS (earnings per share) anticipated at (0.47) USD. Learn more details at JANX Financials page.
Revenue & EPS values are provided in USD
| Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | |
|---|---|---|---|---|---|
| Revenue Reported | 10.00 M | — | 3.73 M | 10.27 M | — |
| Revenue Estimate | 2.87 M | 83.33 K | 4.36 M | 19.07 M | 8.03 M |
| Revenue Surprise | +248.84% | -100.00% | -14.32% | -46.17% | |
| EPS Reported | (0.39) | (0.51) | (0.39) | (0.35) | |
| EPS Estimate | (0.61) | (0.62) | (0.55) | (0.25) | (0.47) |
| EPS Surprise | +36.32% | +18.38% | +29.16% | -39.28% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.